Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Tammy Harutunyan, PharmD Candidate

Articles by Tammy Harutunyan, PharmD Candidate

CAR T cell therapy in leukemia -- Image credit: LASZLO | stock.adobe.com

Introducing Obecabtagene Autoleucel: A New Chapter in ALL Treatment

ByAmir Ali, PharmD, BCOP,Tammy Harutunyan, PharmD Candidate,Arman Melikyan, PharmD Candidate

April 23rd 2025

Obecabtagene autoleucel improves CAR T-cell therapy for B-cell ALL.

Immunotherapy -- Image credit: LASZLO | stock.adobe.com

Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and Melanoma

ByAmin Zakkour Khudari, PharmD Candidate,Tammy Harutunyan, PharmD Candidate,Mohamad Zakour Khadari, MPharm,Rami Madani, MD Candidate,David S. Bateshansky, PharmD, BCOP,Amir Ali, PharmD, BCOP

August 14th 2024

Pharmacists play a vital role in therapy selection.

Pharmacist gathering medication -- Image credit: Arnéll Koegelenberg/peopleimages.com | stock.adobe.com

The Fludarabine Shortage and Its Ripple Effects: Navigating the Crisis

ByJose Tinajero, PharmD, BCOP,Amir Ali, PharmD, BCOP,Tammy Harutunyan, PharmD Candidate,Teny Khachadourian, PharmD Candidate,Michaela Maher, PharmD Candidate

April 22nd 2024

The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.

Latest Updated Articles

Trending on Pharmacy Times

McKesson ideaShare 2026: Recapping Key Insights from Denver

McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up

McKesson ideaShare 2026: What Does It Take to Sustain a Rural Independent Pharmacy? Sandie Kueker, RPh, Explains

Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial

Subcutaneous Isatuximab Gains Approval for MM in Japan Ahead of Anticipated FDA Decision